Insurance and adherence to guideline concordant cervical cancer therapy do not reduce mortality?

Insurance and adherence to guideline concordant cervical cancer therapy do not reduce mortality? Gynecol Oncol. 2020 Nov;159(2):297-298 Authors: Brewster WR PMID: 33092744 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33092744?dopt=Abstract

Source: Gynecologic Oncology - October 25, 2020 Category: Cancer & Oncology Authors: Brewster WR Tags: Gynecol Oncol Source Type: research

More News: Cancer | Cancer & Oncology | Cancer Therapy | Cervical Cancer | Insurance